基于网络药理学预测与分子对接探索牡荆素治疗脑缺血再灌注损伤的潜在药理机制
本研究以人小胶质细胞克隆3细胞行氧糖剥夺/复氧构建脑缺血再灌注损伤(CIRI)细胞模型,并用大脑中动脉闭塞模型评估牡荆素(Vitexin)的体内作用。牡荆素可恢复受损细胞活力、抑制凋亡和炎症因子水平;网络药理学鉴定牡荆素靶点与缺血再灌注相关基因的32个共同基因,PPI网络筛出相互作用最强的前5个基因(PIK3CA、MAPK8、ABL1、JAK2、HDAC6),富集于蛋白磷酸化、ErbB信号通路和MAPK信号通路。分子对接证实牡荆素与5个关键基因结合紧密,Western blot显示牡荆素下调MAPK8蛋白并抑制MAPK信号通路。大鼠实验中牡荆素可有效减轻CIRI,包括脑梗死和炎症反应。
要点
- 在氧糖剥夺/复氧的人小胶质细胞克隆3细胞模型中,牡荆素可恢复细胞活力、抑制凋亡并降低炎症因子水平。
- 网络药理学鉴定牡荆素靶点与缺血再灌注相关基因的32个共同基因,PPI网络筛出相互作用最强的前5个基因:PIK3CA、MAPK8、ABL1、JAK2、HDAC6。
- 32个共同基因主要富集于蛋白磷酸化、ErbB信号通路和MAPK信号通路,牡荆素-基因-通路PPI网络提示MAPK信号通路对牡荆素敏感。
- 分子对接证实牡荆素与5个关键基因结合紧密;Western blot显示牡荆素下调MAPK8蛋白表达并抑制MAPK信号通路。
- 大鼠大脑中动脉闭塞模型中,牡荆素可有效减轻CIRI,包括脑梗死和炎症反应。
适用人群与场景
- 人小胶质细胞克隆3细胞行氧糖剥夺/复氧构建的CIRI细胞模型
- 大鼠大脑中动脉闭塞模型
研究设计与关键结果
- 研究类型:网络药理学预测与分子对接结合细胞实验和动物实验的机制研究。
- 细胞实验:人小胶质细胞克隆3细胞行氧糖剥夺/复氧构建CIRI细胞模型,牡荆素可恢复受损细胞活力,并抑制细胞凋亡和炎症因子水平。
- 网络药理学:Venn图鉴定牡荆素靶点与缺血再灌注相关基因的32个共同基因;PPI网络筛出相互作用最强的前5个基因:PIK3CA、MAPK8、ABL1、JAK2、HDAC6。
- 富集分析:32个共同基因主要富集于蛋白磷酸化、ErbB信号通路和MAPK信号通路。
- 分子对接:牡荆素与5个关键基因结合紧密;Western blot显示牡荆素下调MAPK8蛋白表达并抑制MAPK信号通路。
- 体内实验:大鼠大脑中动脉闭塞模型中,牡荆素可有效减轻CIRI,包括脑梗死和炎症反应。
证据类型、等级与局限
- 证据类型:网络药理学预测、分子对接、细胞实验与动物实验相结合的机制研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本研究为细胞与动物水平的机制探索,作者认为牡荆素可强效结合MAPK8蛋白,从而抑制其表达并阻断MAPK信号通路以有效减轻CIRI。
- 原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cerebral ischemia-reperfusion injury (CIRI) is a key problem to be solved urgently in the treatment of ischemic stroke, which seriously affects the prognosis of patients. As a natural flavonoid, Vitexin has been confirmed to alleviate CIRI, but the molecular network mechanism of its action has not been systematically analyzed.
METHODS: The human microglia clone 3 cells were subjected to construction of cell oxygen-glucose deprivation/reoxygenation treatment to establish a CIRI cell model. The effect of Vitexin on cell viability, apoptosis, and levels of inflammatory factors was determined by cell counting kit 8, terminal deoxynucleotidyl transferase dUTP nick end labeling, and enzyme linked immunosorbent assay methods. The intersection of Vitexin-target genes obtained from the SwissTargetPrediction website and I/R-related genes predicted from the GeneCards website was displayed by a Venn diagram, and the protein-protein interaction (PPI) network between them was constructed through the STRING website to screen key genes. Meanwhile, Gene Ontology and Kyoto Encyclopedia of Genes and Genome analyses of these genes were performed on the DAVID 6.8 database. PPI network of Vitexin-key genes-signaling pathway was then constructed via the STRING website. Molecular docking of Vitexin with key targets was achieved by AutoDock Vina software. Additionally, the expression of MAPK8 and MAPK signaling pathway-related proteins was monitored by Western blot. Besides, the in vivo effect of Vitexin on CIRI was evaluated via an middle cerebral artery occlusion model.
RESULTS: Vitexin could restore the cell viability of human microglia clone 3 cells impaired by construction of cell oxygen-glucose deprivation/reoxygenation, and inhibited cell apoptosis and the levels of inflammatory factors. The Venn diagram identified 32 common genes between Vitexin targets and I/R-related genes. Meanwhile, the top 5 genes (PIK3CA, MAPK8, ABL1, JAK2, and HDAC6) with the strongest interactions were screened via the PPI network. The Gene Ontology and Kyoto Encyclopedia of Genes and Genome analyses of the 32 common genes revealed that they were mainly enriched in protein phosphorylation, the ErbB signaling pathway, and the MAPK signaling pathway. The Vitexin-Genes-Pathways PPI network indicated that the MAPK signaling pathway was sensitive to Vitexin. Molecular docking confirmed that Vitexin had a close binding with five key genes. Moreover, Vitexin downregulated the expression of MAPK8 protein and curbed the MAPK signaling pathway. Vitexin could effectively alleviate CIRI, including cerebral infarction and inflammatory response in rats.
CONCLUSIONS: Through the application of network pharmacology and molecular docking techniques, this study confirmed that Vitexin could strongly bind to the MAPK8 protein, thereby inhibiting its expression and blocking the MAPK signaling pathway to effectively alleviate CIRI.
参考来源
- Dian W, Fu S, Zhang W, et al. A Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Potential Pharmacological Mechanism of Vitexin for Cerebral Ischemia-Reperfusion Injury. Shock. 2025. PMID: 41697135. doi:10.1097/SHK.0000000000002775
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。